Viral hepatitis, IBD co-morbidity

IBD_VIRAL_HEPATITIS

animal viral hepatitis: A hepatitis that involves viral infection of an animal causing inflammation of the liver.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints HEPATITIS_A HEPATITIS_B HEPATITIS_ACUTE_OTHER_VIRAL HEPATITIS_CHRONIC_VIRAL	2754
6. Filter based on genotype QC (FinnGen only)	2490

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	IBD_VIRAL_HEPATITIS
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	HEPATITIS_A\|HEPATITIS_B\|HEPATITIS_ACUTE_OTHER_VIRAL\|HEPATITIS_CHRONIC_VIRAL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral hepatitis, IBD co-morbidity based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2490	1109	1381
Unadjusted period prevalence (%)	0.53	0.39	0.63
Median age at first event (years)	36.16	34.13	37.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2754: Matched controls
27538

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1265

SPAT

Breathalyser

35.3

320.0

203

N05BE01

ATC

buspirone; oral

17.2

317.9

270

173

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

32.7

317.2

206

A10AB05

ATC

insulin aspart; parenteral

70.1

314.2

171

F10.09

ICD-10 Finland

Alcohol intoxication UNS

21.5

311.7

237

120

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

7.1

311.3

533

905

XF400

NOMESCO Finland

ECG with 12 standard connections

6.8

309.2

548

964

X59

ICD-10 Finland

Exposure to unspecified factor

5.3

308.2

772

1875

C07AA05

ATC

propranolol; systemic

5.6

307.7

933

2314

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

48.5

307.7

211

N05AA02

ATC

levomepromazine; systemic

19.7

307.7

457

275

N05AH04

ATC

quetiapine; oral

11.8

307.7

1267

1853

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

11.8

307.7

447

446

T74.1

ICD-10 Finland

Physical abuse

21.2

307.7

281

147

N05BA12

ATC

alprazolam; oral

10.0

307.7

643

811

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

56.0

307.7

411

P19

ICPC

Drug abuse

142.9

307.7

595

A46

ICD-10 Finland

Erysipelas

8.6

307.7

640

937

215

Kela drug reimbursment

Diabetes, non-insulin-treated

501.8

307.7

460

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

112.1

307.7

236

N02BF01

ATC

gabapentin; oral

20.1

307.7

272

149

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

336.7

307.7

427

A10AE04

ATC

insulin glargine; parenteral

141.2

307.7

221

B18.2

ICD-10 Finland

Chronic viral hepatitis C

11755.8

307.7

2033

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

140.6

307.7

220

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

17.5

307.7

275

173

AA1AD

NOMESCO Finland

CT of head and brain

12.7

307.7

844

929

Z72.2

ICD-10 Finland

Drug use

169.2

307.7

367

S06.0

ICD-10 Finland

Concussion

27.8

307.7

454

194

T90

ICPC

Diabetes non-insulin dependent

28.4

307.7

428

177

P15

ICPC

Chronic alcohol abuse

17.6

307.7

384

251

Z2446

NOMESCO Finland

Social worker

12.5

307.7

482

461

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

7.3

307.7

595

1003

N05BA02

ATC

chlordiazepoxide; systemic

24.9

307.7

252

111

N06AB04

ATC

citalopram; systemic

6.5

307.7

906

1939

N06AX16

ATC

venlafaxine; oral

7.2

307.7

684

1212

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

134.9

307.7

165

N03AE01

ATC

clonazepam; systemic

33.8

307.7

521

189

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.9

307.7

615

705

F10.25

ICD-10 Finland

Alcohol dependence continuous use

25.8

307.7

267

114

N05CF01

ATC

zopiclone; oral

5.3

307.7

1074

2941

N05AH03

ATC

olanzapine; systemic

12.0

307.7

725

794

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

310.9

307.7

376

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

32.3

307.7

316

110

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

28.1

307.7

230

N05BA04

ATC

oxazepam; oral

7.3

307.7

1194

2623

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

317.4

307.7

359

N05CD07

ATC

temazepam; oral

15.7

307.7

648

528

N05AX08

ATC

risperidone; systemic

8.8

307.7

493

665

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

546.6

307.7

530

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

41.1

307.7

206

F32.9

ICD-10 Finland

Depressive episode, unspecified

7.6

307.7

759

1318

N05BA01

ATC

diazepam; systemic, rectal

18.6

307.7

1030

859

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

90.8

307.7

397

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.6

307.7

1322

3879

R56.8

ICD-10 Finland

Other and unspecified convulsions

20.2

307.7

348

196

N03AX16

ATC

[U] pregabalin

12.2

307.7

785

869

F29

ICD-10 Finland

Unspecified nonorganic psychosis

11.5

307.7

525

551

F10.20

ICD-10 Finland

Alcohol dependence currently independent

26.7

307.7

295

123

N03AX12

ATC

[U] gabapentin; oral

23.5

307.7

561

297

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

32.6

307.7

581

224

103

Kela drug reimbursment

Diabetes, insulin-treated

386.3

307.7

479

F60.2

ICD-10 Finland

Dissocial personality disorder

129.1

307.7

181

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

18.0

307.7

361

229

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

128.3

307.7

180

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

45.9

307.7

1414

619

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

232.3

307.7

291

SPAT1272

SPAT

Drug screening

123.9

307.7

185

P18

ICPC

Medication abuse

144.7

307.7

226

F10.24

ICD-10 Finland

Alcohol depence active use

26.9

307.7

230

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

142.1

307.7

432

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

26.3

307.7

355

154

E11

ICD-10 Finland

Type 2 diabetes mellitus

26.6

307.7

274

114

Z3231

NOMESCO Finland

Registered nurse

5.3

307.7

989

2622

M79.6

ICD-10 Finland

Pain in limb

4.7

307.7

1135

3590

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

258.6

307.7

454

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

8.1

307.7

620

949

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

17.9

307.7

754

569

N03AG01

ATC

valproic acid; systemic, rectal

14.9

307.7

415

323

N06AX11

ATC

mirtazapine; oral

6.6

307.7

1395

3688

N02AX02

ATC

tramadol; systemic, rectal

6.8

307.7

1295

3165

N07BB01

ATC

disulfiram; oral

15.9

307.7

543

419

T36

ICD-10 Finland

Poisoning by systemic antibiotics

32.9

307.7

701

283

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

188.4

307.7

225

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

39.1

307.7

307

A10BA02

ATC

metformin; oral

29.1

307.7

471

194

N06AX21

ATC

duloxetine; oral

9.2

307.0

403

505

N05AF03

ATC

chlorprothixene; systemic

14.5

305.3

285

217

N06AB06

ATC

sertraline; oral

6.2

305.2

607

1196

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

159.7

304.5

151

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

124.5

302.1

153

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

19.4

301.0

240

135

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

798.4

296.7

287

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

13.6

295.0

286

232

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

5.8

294.2

638

1360

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

130.3

293.5

148

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.0

292.4

798

2074

A10BK03

ATC

empagliflozin; oral

105.7

291.3

150

Z3226

NOMESCO Finland

Physiotherapist

6.1

290.2

589

1180

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

75.1

289.8

156

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

45.2

286.7

170

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

2885.3

286.3

272

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.5

286.0

534

986

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

390.0

285.9

283

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

6.3

284.9

555

1068

N06AA12

ATC

doxepin; systemic

14.1

284.6

270

211

EBA00

NOMESCO Finland

Extraction of tooth

4.0

283.9

1382

5500

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

52.1

282.0

162

A49.9

ICD-10 Finland

Bacterial infection, unspecified

8.2

278.1

403

567

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

42.3

277.0

167

NA1AD

NOMESCO Finland

Cervical spine CT examination

20.1

273.8

214

115

N06AB03

ATC

fluoxetine; oral

6.1

273.1

546

1075

C03CA01

ATC

furosemide; systemic

6.3

270.9

520

984

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

40.5

269.2

164

R4110

NOMESCO Finland

Physiotherapy

4.6

268.7

839

2411

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

7.3

267.1

432

686

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

20.2

266.9

208

111

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

406.2

262.8

260

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

401.0

259.6

257

M54.5

ICD-10 Finland

Low back pain

4.1

258.9

1012

3419

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

27.3

257.4

177

TPH04

NOMESCO Finland

Cathetrisation of vein

4.9

256.4

688

1748

SPAT1254

SPAT

Administration of medicine

6.5

255.8

468

843

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

314.7

255.6

256

N03AX09

ATC

lamotrigine; oral

10.4

253.7

296

316

K04.5

ICD-10 Finland

Chronic apical periodontitis

4.0

249.2

1010

3487

J01FF01

ATC

clindamycin; systemic

4.2

249.1

899

2859

G47.3

ICD-10 Finland

Sleep apnoea

8.2

248.7

354

486

F60.9

ICD-10 Finland

Personality disorder, unspecified

23.1

248.2

182

B17.1

ICD-10 Finland

Acute hepatitis C

+∞

247.7

234

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

26.4

245.6

171

N05AX12

ATC

aripiprazole; systemic

8.0

243.9

356

503

A06AD11

ATC

lactulose; oral

6.7

243.3

427

736

SPAT1227

SPAT

Substance abuse rehabilitation

42.8

243.1

146

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

11.8

239.6

254

236

N05AD01

ATC

haloperidol; systemic

12.9

238.7

238

201

N06AB10

ATC

escitalopram; oral

4.1

238.1

852

2683

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

19.4

236.2

187

103

A02BC02

ATC

pantoprazole; systemic

3.7

235.6

1730

8707

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.2

235.2

824

2553

EBA30

NOMESCO Finland

Extraction of root of tooth

8.7

234.0

314

401

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.6

233.1

1350

5846

M54.4

ICD-10 Finland

Lumbago with sciatica

6.4

232.3

429

777

P16

ICPC

Acute alcohol abuse

16.3

230.1

199

131

A01

ICPC

Pain general/multiple sites

8.6

228.0

310

402

N05CF02

ATC

zolpidem; oral

4.6

227.1

661

1778

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

23.5

225.5

164

G56.0

ICD-10 Finland

Carpal tunnel syndrome

11.7

225.0

238

220

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

7.7

224.6

336

487

M48.0

ICD-10 Finland

Spinal stenosis

48.7

223.2

130

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.6

220.7

1120

4431

F61.0

ICD-10 Finland

Mixed personality disorders

18.1

220.1

180

106

S18

ICPC

Laceration/cut

3.5

216.1

1172

4822

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.4

215.9

669

1882

A28

ICPC

Limited function/disability NOS

7.7

214.8

320

461

L17

ICPC

Foot/toe symptom/complaint

4.0

212.3

759

2368

M54.9

ICD-10 Finland

Dorsalgia, unspecified

6.9

207.7

348

569

N02BF02

ATC

pregabalin; oral

13.1

207.3

203

166

N06AB05

ATC

paroxetine; oral

7.0

204.3

334

532

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

29.8

204.2

136

N03AF01

ATC

carbamazepine; oral, rectal

17.8

204.2

168

100

S97

ICPC

Chronic ulcer skin

14.0

202.2

190

145

EBA05

NOMESCO Finland

Complicated extraction of tooth

3.7

202.2

851

2958

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

20.6

200.5

154

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

3.3

199.9

1569

7960

WX892

NOMESCO Finland

Monitored bed care

7.6

199.6

302

442

WX110

NOMESCO Finland

Infiltration anesthesia

4.0

199.2

2206

13763

ZY010

NOMESCO Finland

Hospital outpatient

7.2

197.0

312

480

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

10.2

196.0

228

241

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

10.5

195.1

223

230

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

9.1

193.9

248

297

A41.9

ICD-10 Finland

Sepsis, unspecified

17.2

192.5

161

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

23.0

191.3

140

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

9.1

191.0

243

289

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

501.5

190.8

188

ZY000

NOMESCO Finland

Hospital inpatient

15.9

189.2

165

110

Z2221

NOMESCO Finland

Medical doctor

3.4

188.3

938

3609

M25.5

ICD-10 Finland

Pain in joint

3.8

188.1

713

2298

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

11.3

187.0

202

192

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

8.5

186.0

251

321

EBA15

NOMESCO Finland

Extraction of multiple teeth

10.2

185.5

215

226

N05AB01

ATC

dixyrazine; systemic

29.9

185.2

123

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

6.8

184.9

308

499

ZXE10

NOMESCO Finland

More than one and less than three hours

3.4

184.8

924

3558

N05AH02

ATC

clozapine; systemic

8.8

182.8

239

294

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

7.6

182.3

273

394

F20.9

ICD-10 Finland

Schizophrenia, unspecified

8.8

182.0

237

290

L28

ICPC

Limited function/disability (L)

6.9

181.5

297

472

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

6.8

181.1

303

493

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

71.8

178.9

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

6.7

178.7

304

503

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

23.7

178.5

129

P29

ICPC

Psychological sympt/compl other

5.3

177.9

394

837

K08.3

ICD-10 Finland

Retained dental root

6.1

177.5

331

600

R4120

NOMESCO Finland

Occupational therapy

10.5

176.8

200

203

Z71.8

ICD-10 Finland

Other specified counselling

3.2

174.6

1004

4181

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

3.2

174.1

987

4076

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

5.0

173.0

412

931

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

5.5

172.5

367

752

K05.31

ICD-10 Finland

Periodontitis pronounced

5.3

172.2

383

816

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

3.1

171.9

1728

9790

M17.1

ICD-10 Finland

Other primary gonarthrosis

9.1

171.2

218

259

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

8.9

169.9

220

267

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

4.1

169.7

540

1530

ZXD05

NOMESCO Finland

Urgent procedure

3.2

169.5

959

3946

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

5.4

168.8

367

766

R02

ICPC

Shortness of breath/dyspnoea

5.5

167.4

352

713

L03

ICPC

Low back symptom/complaint

3.5

166.2

721

2520

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

7.1

166.1

264

406

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

8.6

165.3

220

276

ZXD35

NOMESCO Finland

Usual procedure

11.3

164.5

177

167

N03AF02

ATC

oxcarbazepine; oral

59.4

164.4

A10BK01

ATC

dapagliflozin; oral

59.4

164.4

-1, ,

NOMESCO Finland

3.0

164.2

1185

5573

S01.0

ICD-10 Finland

Open wound of scalp

5.8

163.8

324

620

ZXA05

NOMESCO Finland

Left side

4.0

163.3

549

1615

SPAT1148

SPAT

Treatment of chronic ulcer or burn

5.9

163.1

313

582

S10

ICPC

Boil/carbuncle

6.8

161.1

267

429

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.0

161.0

1054

4688

Y07

ICD-10 Finland

Other maltreatment

21.6

160.0

120

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.9

160.0

259

406

L12

ICPC

Hand/finger symptom/complaint

4.1

158.7

502

1412

N06AA09

ATC

amitriptyline; systemic

8.9

158.2

204

246

ZXA00

NOMESCO Finland

Right side

3.9

158.1

550

1655

N05CD08

ATC

midazolam; nasal, systemic

22.2

157.8

117

WX002

NOMESCO Finland

Sedation and analgesia

4.1

157.7

494

1379

TKC20

NOMESCO Finland

Catheterisation of bladder

7.7

157.4

229

319

WX408

NOMESCO Finland

General anesthesy, balanced

3.4

156.8

712

2551

R50.9

ICD-10 Finland

Fever, unspecified

4.1

156.5

495

1391

N02BE01

ATC

paracetamol; systemic, rectal

3.8

156.2

2302

15812

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

15.2

155.3

138

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

10.9

155.1

171

167

Z72.1

ICD-10 Finland

Alcohol use

18.0

154.8

126

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.2

154.6

473

1297

N06AX03

ATC

mianserin; oral

9.6

154.0

186

206

WYA30, ,

SPAT

37.8

153.5

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

76.8

152.7

NE1AA

NOMESCO Finland

Pelvis X-ray examination

14.6

152.6

139

100

D72

ICPC

Viral hepatitis

324.2

151.3

152

A02BC01

ATC

omeprazole; systemic

3.5

151.2

656

2279

K02.1

ICD-10 Finland

Caries of dentine

3.0

150.7

1917

11975

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

6.3

149.6

265

455

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

26.7

149.4

103

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

10.1

148.8

173

182

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

317.2

148.1

149

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

6.2

147.7

270

478

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

201.0

147.3

152

N06AX12

ATC

bupropion; oral

5.0

147.3

345

765

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

7.3

147.2

226

334

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

8.4

146.3

198

253

ZXE00

NOMESCO Finland

One hour or less

2.9

146.3

1072

5018

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

7.2

146.1

228

343

R51.80

ICD-10 Finland

Headache

4.4

145.6

403

1022

SPAT1262

SPAT

Handing over of treatment supplies

6.2

145.6

263

460

V03AA01, ,

ATC

17.7

145.1

119

N05AB03

ATC

perphenazine; systemic, rectal

7.4

144.9

220

321

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

9.4

144.8

177

199

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

258.6

144.7

147

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

46.1

144.3

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

196.8

144.2

149

F90.0

ICD-10 Finland

Disturbance of activity and attention

6.5

144.1

247

410

WX290

NOMESCO Finland

Other blockage of nerve

2.8

144.1

1611

9330

R5140

NOMESCO Finland

Monitoring the use of the aid

13.3

143.4

138

109

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

6.1

142.7

261

462

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

12.9

142.0

139

113

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

13.0

141.9

138

111

S76

ICPC

Skin infection other

7.7

141.8

207

289

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

13.1

141.0

137

110

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

24.7

140.9

100

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

32.4

140.7

IGV01

NOMESCO Finland

Psychiatric network contact

16.9

139.5

117

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

21.6

138.9

104

R06.0

ICD-10 Finland

Dyspnoea

3.5

138.5

567

1890

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

18.7

137.9

110

C07AB07

ATC

bisoprolol; oral

2.9

137.9

878

3793

R05

ICPC

Cough

3.2

136.4

667

2479

A10AC01

ATC

insulin (human); parenteral

16.4

134.9

115

A10BH01

ATC

sitagliptin; oral

691.1

134.9

132

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

8.6

134.7

177

218

L03.9

ICD-10 Finland

Cellulitis, unspecified

13.7

134.6

127

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.7

134.6

499

1557

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

4.2

134.5

405

1092

Z76.0

ICD-10 Finland

Issue of repeat prescription

3.0

134.5

774

3157

SAA01

NOMESCO Finland

Simple examination of mouth

3.1

134.1

2163

14877

P99

ICPC

Psychological disorders other

7.4

133.6

201

290

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

15.4

132.9

117

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

345.9

132.8

133

K04.0

ICD-10 Finland

Pulpitis

3.9

132.6

451

1326

N05AD03

ATC

melperone; systemic

22.8

132.6

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

11.3

132.1

141

131

K04.7

ICD-10 Finland

Periapical abscess without sinus

5.3

132.1

288

599

N04AA02

ATC

biperiden; systemic

10.5

131.8

148

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

58.5

131.8

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

4.2

131.7

399

1080

IFC01, ,

SPAT

1329.8

131.4

127

P01AB01

ATC

metronidazole; oral, rectal

2.7

131.2

1070

5233

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

19.1

130.3

103

F51.0

ICD-10 Finland

Nonorganic insomnia

3.4

130.2

579

2027

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

36.3

129.4

P06

ICPC

Sleep disturbance

4.4

128.5

360

918

N05BA06

ATC

lorazepam; systemic, sublingual

6.7

128.3

211

335

W19

ICD-10 Finland

Unspecified fall

5.0

128.3

296

646

P74

ICPC

Anxiety disorder/anxiety state

6.1

128.2

235

416

TPH07

NOMESCO Finland

Cathetrisation of artery

4.8

127.6

308

698

N05AN01

ATC

lithium; oral

8.9

127.4

163

194

X57

ICD-10 Finland

Unspecified privation

11.9

127.4

131

115

NF1AA

NOMESCO Finland

Hip X-ray examination

15.3

126.8

112

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

647.1

126.4

124

SPAT1260

SPAT

Consultation of another employee

3.7

126.3

455

1389

J01DB01

ATC

cefalexin; oral

3.3

126.2

2285

16434

N06BA04

ATC

methylphenidate; oral

6.5

125.6

213

349

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

17.9

125.3

102

P01

ICPC

Feeling anxious/nervous/tense

3.5

123.0

503

1667

D11

ICPC

Diarrhoea

3.8

122.9

433

1301

0709X

ICD-9 Finland

Viral hepatitis, Unspecified viral hepatitis without mention of hepatic coma

+∞

122.8

117

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

11.2

122.5

131

122

N05AA01

ATC

chlorpromazine; systemic, rectal

11.8

122.2

126

111

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

19.6

121.9

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

418.9

121.7

121

R11

ICD-10 Finland

Nausea and vomiting

5.2

121.6

264

546

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

23.3

121.3

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

619.6

121.2

119

F05.9

ICD-10 Finland

Delirium, unspecified

21.6

120.4

X58

ICD-10 Finland

Exposure to other specified factors

3.5

120.4

471

1516

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

7.8

119.4

171

233

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

34.0

119.2

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

41.0

118.9

D10

ICPC

Vomiting

4.6

118.6

301

709

SPAT1240

SPAT

Therapeutic discussion

3.7

117.8

417

1255

ZXD10

NOMESCO Finland

Scheduled procedure

2.7

117.7

897

4200

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

117.5

112

ZXE20

NOMESCO Finland

More than three and less than five hours

4.1

117.4

363

994

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

49.8

117.3

R52.2

ICD-10 Finland

Other chronic pain

14.0

117.3

109

M13.9

ICD-10 Finland

Arthritis, unspecified

10.5

117.2

131

130

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.4

117.2

489

1638

A03

ICPC

Fever

3.1

117.1

610

2333

SPAT1301

SPAT

No procedures

2.9

117.0

715

2986

IFC99

NOMESCO Finland

Other biological psychiatric intervention

56.3

116.7

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

6.4

116.6

200

331

T51.0

ICD-10 Finland

Toxic effect: Ethanol

22.2

116.3

ACC51

NOMESCO Finland

Release of median nerve

307.4

116.1

117

F41.09

ICD-10 Finland

UNS Panic Syndrome

7.5

115.5

171

242

Y09

ICD-10 Finland

Assault by unspecified means

29.3

115.4

N05CD02

ATC

nitrazepam; oral

27.1

115.3

N06AA06

ATC

trimipramine; systemic

11.5

114.9

121

110

SPE90

NOMESCO Finland

Other partial denture

15.7

114.8

100

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

22.8

114.8

R60.0

ICD-10 Finland

Localized oedema

5.0

114.1

260

560

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

21.1

113.9

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

21.1

113.9

K02.9

ICD-10 Finland

Dental caries, unspecified

10.3

113.5

129

131

XCK10

NOMESCO Finland

Photography of fundus of eye

6.5

113.5

191

310

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.2

113.4

173

253

G40.9

ICD-10 Finland

Epilepsy, unspecified

576.0

112.8

111

Z2445

NOMESCO Finland

Psychologist

6.9

112.0

178

272

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

24.6

111.3

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

24.6

111.3

IGY02

NOMESCO Finland

Psychiatric monitoring contact

6.8

111.3

179

277

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

10.0

110.8

128

133

X78

ICD-10 Finland

Intentional self-harm by sharp object

18.4

110.7

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

21.4

110.5

R52.9

ICD-10 Finland

Pain, unspecified

4.7

110.4

273

629

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

3.3

110.3

472

1602

SPAT1247

SPAT

Outpatient detoxication and monitoring

27.5

110.0

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

+∞

109.1

104

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

108.9

601

2365

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.4

108.7

447

1479

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.5

108.7

219

423

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

49.6

108.5

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

38.1

108.5

JN3AD

NOMESCO Finland

Abdominal CT examination

4.1

108.5

322

854

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.9

108.4

205

373

M01AE03

ATC

ketoprofen; systemic, rectal

2.7

108.4

799

3658

WX730

NOMESCO Finland

Conventional respirator

16.4

108.2

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

13.5

107.9

102

RS220, ,

NOMESCO Finland

14.7

107.8

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

61.3

107.7

A02BC03

ATC

lansoprazole; oral

3.0

107.6

595

2343

M16.1

ICD-10 Finland

Other primary coxarthrosis

15.7

107.1

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.0

107.1

242

517

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

22.9

106.9

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

6.3

106.9

186

312

M03BC01

ATC

orphenadrine (citrate); systemic

3.0

106.2

574

2230

J01CF05

ATC

flucloxacillin; systemic

5.2

106.1

231

478

N07BA03

ATC

varenicline; oral

5.4

105.4

217

427

F39

ICD-10 Finland

Unspecified mood [affective] disorder

8.6

105.4

137

166

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

5.4

105.0

219

436

F99

ICD-10 Finland

Mental disorder, not otherwise specified

8.3

104.9

141

178

N01

ICPC

Headache

3.9

104.9

345

984

K92.0

ICD-10 Finland

Haematemesis

10.9

104.6

114

109

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

9.8

104.2

122

129

F43.1

ICD-10 Finland

Post-traumatic stress disorder

8.3

104.0

140

177

N02AA05

ATC

oxycodone; systemic

4.1

104.0

313

838

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

10.2

103.7

118

120

C03DA01

ATC

spironolactone; oral

5.0

103.7

237

511

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

7.8

103.5

147

198

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.3

103.0

217

436

SPAT1222

SPAT

Counselling/guidance promoting independent living

4.2

102.9

292

748

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

353.4

102.9

103

Z3229

NOMESCO Finland

Other healthcare associate professional

5.2

102.8

221

452

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

44.5

102.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

4.3

102.5

288

732

L86

ICPC

Back syndrome with radiating pain

7.7

102.2

147

201

N05AF05

ATC

zuclopenthixol; systemic

11.6

101.5

106

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

267.7

101.5

103

IEV99

NOMESCO Finland

Other psychiatric network intervention

20.0

101.1

B15.9

ICD-10 Finland

Hepatitis A without hepatic coma

+∞

100.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

17.0

100.6

R74

ICPC

Upper respiratory infection acute

2.4

100.3

1042

5565

Z72.0

ICD-10 Finland

Tobacco use

8.7

99.9

129

155

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

31.7

99.9

XA800

NOMESCO Finland

Neuropsychological investigation

12.9

99.5

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.2

99.4

214

438

QCA10

NOMESCO Finland

Incision of skin of upper limb

57.1

99.2

N02AJ06

ATC

codeine and paracetamol; systemic

2.5

98.5

898

4516

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.9

98.0

545

2143

P72

ICPC

Schizophrenia

6.6

97.8

161

255

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

152.8

97.8

103

SPAT1310

SPAT

Counselling related to known health issue

2.6

97.6

723

3295

-50

ICPC

Medication/prescr/renewal

8.2

97.1

131

166

J01MA12

ATC

levofloxacin; systemic

3.2

97.1

436

1517

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.2

97.0

283

739

C08CA01

ATC

amlodipine; oral

2.7

96.8

633

2710

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

4.4

96.7

256

621

SGA01

NOMESCO Finland

Emergency treatment

2.8

96.7

607

2544

K10.3

ICD-10 Finland

Alveolitis of jaws

5.4

96.3

197

385

A10AE05

ATC

insulin detemir; parenteral

205.3

96.0

SFA30

NOMESCO Finland

Three-surface restoration

2.3

95.9

1183

6771

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.5

95.8

770

3645

ZXY60

NOMESCO Finland

2-person team, nurses

17.8

95.7

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

132.3

95.7

102

N06AX05

ATC

trazodone; oral

9.8

95.3

112

119

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

203.1

95.0

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

94.3

KMAK, ,

NOMESCO Finland

2.3

94.1

1608

10503

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

9.0

93.8

118

137

SPAT1283

SPAT

Restricted health certificate

2.7

93.7

638

2783

SPAT1234

SPAT

Support of social functional capacity

7.3

93.6

140

200

R53

ICD-10 Finland

Malaise and fatigue

2.8

93.3

576

2389

R41.0

ICD-10 Finland

Disorientation, unspecified

15.7

93.3

G56.2

ICD-10 Finland

Lesion of ulnar nerve

17.2

92.9

L15

ICPC

Knee symptom/complaint

3.1

92.8

451

1641

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

16.7

92.7

X84

ICD-10 Finland

Intentional self-harm by unspecified means

40.8

92.2

A97

ICPC

No disease

2.9

92.0

501

1943

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

11.8

91.6

G44.2

ICD-10 Finland

Tension-type headache

4.0

91.5

278

747

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

8.0

91.3

126

164

S29

ICPC

Skin symptom/complaint other

3.0

91.2

482

1838

N06AA10

ATC

nortriptyline; systemic

20.8

90.9

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

5.5

90.9

184

356

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

13.4

90.7

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.1

90.0

161

277

Z01.8

ICD-10 Finland

Other specified special examinations

3.0

89.8

468

1770

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

6.4

89.6

152

248

M79.1

ICD-10 Finland

Myalgia

3.5

89.6

341

1068

SFA10

NOMESCO Finland

One-surface restoration

2.2

89.3

1559

10189

F92.0

ICD-10 Finland

Depressive conduct disorder

35.7

89.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

10.0

89.0

103

107

ZZA00

NOMESCO Finland

Split skin graft

10.4

88.6

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

9.7

88.1

104

111

J45.9

ICD-10 Finland

Asthma, unspecified

3.1

88.1

424

1532

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

9.1

88.0

109

124

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

10.0

87.9

101

104

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

6.9

87.8

138

208

N03AX14

ATC

levetiracetam; systemic

22.6

87.3

N06AX26

ATC

vortioxetine; oral

4.0

87.0

264

708

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.2

86.9

380

1297

WVA20, ,

SPAT

8.6

86.8

113

137

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

50.9

86.5

SPAT1249

SPAT

Treatment-related counselling outside office

2.3

86.5

908

4810

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

120.3

86.5

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

85.9

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

28.2

85.8

M19.0

ICD-10 Finland

Primary arthrosis of other joints

8.2

85.5

115

145

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

6.5

85.5

143

230

Z01.2

ICD-10 Finland

Dental examination

2.2

85.4

1303

8026

SPAT1263

SPAT

Sampling

2.3

85.3

961

5239

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

29.1

85.2

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

297.5

85.2

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

11.6

84.8

Z22.5

ICD-10 Finland

Carrier of viral hepatitis

430.5

84.5

B01AB05

ATC

enoxaparin; parenteral

2.6

84.4

576

2502

K59.09

ICD-10 Finland

Constipation, unspecified

5.9

84.4

156

277

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

5.9

84.3

155

274

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.9

84.1

156

278

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

843.4

84.0

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

15.6

83.8

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.7

83.8

160

293

D01

ICPC

Abdominal pain/cramps general

3.4

83.8

325

1029

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

+∞

83.8

SPAT1215

SPAT

Assessment of need for medical rehabilitation

7.3

82.9

124

177

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

6.9

82.7

131

199

K04.1

ICD-10 Finland

Necrosis of pulp

3.1

82.5

394

1414

TAB00

NOMESCO Finland

Lumbar puncture

9.1

82.4

102

116

K02.2

ICD-10 Finland

Caries of cementum

5.8

82.4

155

280

WZC00

NOMESCO Finland

Treatment plan or consultation

2.3

82.3

902

4847

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

19.0

82.3

R03AC02

ATC

salbutamol; inhalant

2.1

82.0

1331

8357

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

216.5

81.8

F20.0

ICD-10 Finland

Paranoid schizophrenia

11.5

81.5

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

113.6

81.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.5

81.2

670

3180

P76

ICPC

Depressive disorder

4.1

80.7

240

634

S22.3

ICD-10 Finland

Fracture of rib

4.6

80.6

201

464

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

7.9

80.1

111

145

K04.08

ICD-10 Finland

Other specified pulpit

3.4

80.0

313

995

RS221, ,

NOMESCO Finland

15.7

79.6

T89

ICPC

Diabetes insulin dependent

110.9

79.4

J01DA01

ATC

[U] cefalexin

2.1

79.3

1558

10471

L08

ICPC

Shoulder symptom/complaint

2.8

79.0

446

1754

XF600

NOMESCO Finland

Bloodpressure measurement

5.6

78.8

154

288

WX872

NOMESCO Finland

Intensive care

5.7

78.8

152

281

SGA02

NOMESCO Finland

Opening and preparing the root canals

2.9

78.7

411

1549

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

28.4

78.6

A02BC05

ATC

esomeprazole; systemic

2.3

78.5

863

4628

ZYC01

NOMESCO Finland

Remote contact by phone

4.8

78.2

185

409

Z03

ICPC

Housing/neighbourhood problem

21.9

78.2

WX110, ,

SPAT

3.7

78.1

268

782

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

4.2

77.8

217

546

SPAT1216

SPAT

Assessment of functional ability

4.2

77.8

217

546

IGY99

NOMESCO Finland

Other psychiatric treatment contact

7.4

77.7

114

159

SFA20

NOMESCO Finland

Two-surface restoration

2.1

77.7

1681

11680

A41.8

ICD-10 Finland

Other specified sepsis

14.3

77.7

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

17.2

77.4

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.5

77.2

198

467

JN5BD

NOMESCO Finland

Head and body CT examination for trauma

16.6

77.2

SPAT1281

SPAT

Other administrative function

4.2

77.1

217

550

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

20.1

76.6

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

10.7

76.5

N04BC05

ATC

pramipexole; oral

6.9

76.2

119

178

P17

ICPC

Tobacco abuse

12.0

75.8

G56.3

ICD-10 Finland

Lesion of radial nerve

34.9

75.8

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

758.6

75.6

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

8.0

75.5

104

135

R44.0

ICD-10 Finland

Auditory hallucinations

29.9

75.4

IGY02, ,

SPAT

9.4

75.4

100

A04

ICPC

Weakness/tiredness general

3.2

75.3

338

1167

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

105.6

75.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

26.5

75.3

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

3.3

75.2

310

1017

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

2.3

75.1

734

3737

S51.8

ICD-10 Finland

Open wound of other parts of forearm

12.2

74.8

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

2.5

74.5

570

2601

F20

ICD-10 Finland

Schizophrenia

11.4

74.5

TK800

NOMESCO Finland

Hemodialysis

12.7

74.5

Z00.0

ICD-10 Finland

General medical examination

2.7

74.3

475

1987

F40.1

ICD-10 Finland

Social phobias

5.4

74.2

151

293

R03BB04

ATC

tiotropium bromide; inhalant

4.7

74.2

179

402

P01BA02

ATC

hydroxychloroquine; oral

11.1

74.0

SPA47

NOMESCO Finland

Precision impression for denture

8.7

74.0

113

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

256.9

73.7

F61

ICD-10 Finland

Mixed and other personality disorders

21.6

73.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

73.3

512

2237

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

+∞

73.2

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

+∞

73.2

F31.8

ICD-10 Finland

Other bipolar affective disorders

7.8

73.2

103

137

M54.2

ICD-10 Finland

Cervicalgia

4.9

73.2

169

366

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

7.3

73.0

109

155

IHZ04, ,

SPAT

10.7

72.9

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

72.9

573

2646

WX203

NOMESCO Finland

Infraclavicular plexus blockade

8.8

72.1

106

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

11.3

72.1

Z02.7

ICD-10 Finland

Issue of medical certificate

4.1

71.8

208

538

G51.0

ICD-10 Finland

Bell palsy

33.4

71.7

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

249.8

71.7

M01AE02

ATC

naproxen; oral, rectal

2.0

71.6

1306

8431

SPAT1307

SPAT

Psychosocial counselling and guidance

3.6

71.4

251

743

S01

ICPC

Pain/tenderness of skin

6.0

71.3

129

224

QCB00

NOMESCO Finland

Suture of skin of upper limb

8.1

71.3

124

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

3.2

71.0

306

1030

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.1

71.0

330

1162

M01AB05

ATC

diclofenac; systemic, rectal

2.0

70.7

1561

10770

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1165

3801

4.58

323.31

3.9

2.2

56.49

78.34

u/l

0.80

1062

3545

(3030467) Casts [#/volume] in Urine by Automated count

1061

3225

4.72

323.01

3.3

2.2

0.58

0.45

e6/l

0.58

790

2213

(3042936) Bacteria identified in Isolate by Culture

687

1453

5.97

321.39

2.7

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1265

4407

4.46

321.26

3.9

2.5

46.02

91.82

e6/l

1.60

863

2789

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

503

794

7.53

314.69

1.5

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

484

735

7.78

313.57

2.1

2.5

12.92

11.03

g/l

9.54

457

681

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

51.98

312.97

3.9

1.1

25385001.77

—

iu/ml

—

(3002582) Erythrocytes [#/volume] in Urine

1110

3579

4.52

311.11

3.3

2.2

84.82

92.87

e6/l

0.06

828

2539

(3003458) Phosphate [Moles/volume] in Serum or Plasma

599

1152

6.37

309.02

7.6

5.3

1.03

1.01

mmol/l

0.93

574

1089

(3019198) Lymphocytes [#/volume] in Blood

1890

7329

6.03

307.65

9.1

4.7

2.08

1.96

e9/l

3.03

1694

6491

(3006504) Eosinophils/100 leukocytes in Blood

1785

6720

5.71

307.65

8.7

4.8

2.70

2.92

4.01

1706

6322

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2458

11105

12.29

307.65

11.3

6.1

84.24

75.67

u/l

12.15

2392

10460

(3021879) Hepatitis B virus core Ab [Presence] in Serum

900

1750

7.15

307.65

1.9

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

832

1089

10.51

307.65

2.8

2.4

0.20

0.22

g/l

14.92

754

1040

(3016650) Hepatitis A virus Ab [Presence] in Serum

373

282

15.14

307.65

1.2

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1304

2337

9.70

307.65

10.7

1.8

7.10

9.20

mmol/l

23.84

1163

2100

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1455

4554

5.65

307.65

8.0

4.6

1.20

1.21

mmol/l

7.37

1361

4164

(3028300) Cannabinoids [Presence] in Urine

910

1489

8.63

307.65

12.5

1.5

—

(3011288) Drugs identified in Urine by Screen method

897

809

15.96

307.65

15.7

2.0

—

(3001604) Monocytes [#/volume] in Blood

1870

6963

6.25

307.65

9.0

4.8

0.58

0.56

e9/l

4.52

1657

6017

(3017143) Hepatitis C virus Ab [Presence] in Serum

1240

2576

7.94

307.65

2.0

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

1460

3552

7.62

307.65

6.4

3.3

89.12

93.23

7.77

1415

3482

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

350

274

14.49

307.65

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

457

392

13.78

307.65

1.2

1.5

89.34

148.54

titre

0.46

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2193

6816

11.88

307.65

8.5

6.3

12.58

12.22

umol/l

0.39

2112

6502

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1015

2259

6.53

307.65

2.9

1.6

378.91

225.08

u/l

2.01

965

2133

(3027008) Opiates [Presence] in Urine

904

1490

8.54

307.65

11.8

1.5

—

(3006315) Basophils [#/volume] in Blood

1874

6972

6.28

307.65

9.0

4.8

0.04

e9/l

3.02

1656

6019

(3002030) Lymphocytes/100 leukocytes in Blood

1809

7161

5.45

307.65

8.7

4.7

30.40

29.39

2.89

1728

6773

(3027944) Amphetamines [Presence] in Urine

883

1477

8.33

307.65

11.8

1.5

—

(40758558) Short blood count panel - Blood

1221

3569

5.35

307.65

10.0

7.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1199

3937

4.62

307.65

2.0

1.5

96.63

95.93

pmol/l

0.20

642

2172

(3013115) Eosinophils [#/volume] in Blood

1907

7312

6.23

307.65

10.1

5.2

0.18

0.19

e9/l

0.56

1697

6427

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1299

2973

7.38

307.65

3.3

1.6

1.66

1.28

56.00

1161

2748

(46235355) HIV 1 and 2 tests - Meaningful Use set

1627

5139

6.29

307.65

2.7

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1805

6468

6.20

307.65

8.6

5.1

—

(3002032) Base excess in Venous blood by calculation

485

709

8.09

307.65

4.1

2.6

1.59

1.96

mmol/l

1.10

394

600

(3018010) Neutrophils/100 leukocytes in Blood

1787

7041

5.38

307.65

8.6

4.6

54.67

56.04

4.50

1709

6654

(3019069) Monocytes/100 leukocytes in Blood

1794

6763

5.74

307.65

8.9

5.0

8.45

8.44

0.05

1717

6370

(3022217) INR in Platelet poor plasma by Coagulation assay

1553

4644

6.37

307.65

9.2

7.7

1.12

1.18

inr

2.77

452

1383

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

748

1576

6.14

307.65

3.3

2.7

12.55

9.29

umol/l

1.66

621

1413

(3028707) Methadone [Presence] in Urine by Screen method

749

408

24.84

307.65

11.9

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

858

1038

11.55

307.65

11.9

1.6

—

(3016879) Cocaine [Presence] in Urine

905

1356

9.45

307.65

12.1

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1522

5129

5.40

307.65

8.8

5.0

1.20

1.21

mmol/l

11.02

1322

4344

(3023368) Bacteria identified in Blood by Culture

1119

2714

6.26

307.65

7.2

3.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

488

714

8.09

307.65

4.2

2.6

5.87

5.82

kpa

0.41

462

694

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

944

255.95

307.65

2.1

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1877

5006

9.63

307.65

6.0

5.0

35.99

36.64

g/l

4.19

1791

4685

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1557

3988

7.68

307.65

2.2

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

683

1268

6.83

307.65

1.3

1.2

246.67

322.97

titre

0.97

138

175

(3022096) Basophils/100 leukocytes in Blood

1754

6465

5.72

307.65

8.6

4.9

0.66

0.68

0.73

1675

6055

(3036180) Methadone [Presence] in Urine

322

110

33.01

307.65

5.7

2.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2031

8499

6.29

307.65

16.2

9.0

3.97

3.92

e9/l

0.42

1829

7342

(3000764) Benzodiazepines [Presence] in Urine

909

1478

8.69

307.65

12.3

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

285

172

18.37

307.65

3.3

2.9

37.73

37.92

umol/l

0.03

268

166

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1969

5238

10.68

307.65

5.9

3.0

55.48

33.81

u/l

11.64

1869

5014

(3018418) pH of Serum or Plasma

1038

2924

5.09

307.65

4.3

3.4

7.39

7.40

2.17

180

543

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

565

+∞

307.65

1.2

0.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1824

7183

5.56

307.65

7.5

3.3

6.64

6.04

mmol/l

15.11

1723

6495

(3021589) Normoblasts [#/volume] in Blood

1693

6674

4.99

307.65

12.6

6.6

0.00

e9/l

0.35

1422

5350

(44816559) Phosphatidylethanol [Mass/volume] in Blood

350

328

12.08

307.65

2.0

1.3

—

(36304419) Bacteria [Presence] in Urine

1044

3253

4.56

305.34

3.2

2.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

563

1037

6.57

303.18

4.6

2.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

640

1362

5.82

295.77

3.2

2.4

30.83

42.64

u/l

2.08

565

1200

(3012516) Albumin [Mass/volume] in Urine

680

1542

5.53

292.58

3.4

1.8

305.56

704.14

mg/l

1.04

444

838

(3020682) Albumin/Creatinine [Ratio] in Urine

704

1660

5.35

289.41

4.1

2.1

21.59

10.58

mg/mmol

2.14

450

924

(3013707) Erythrocyte sedimentation rate by Westergren method

1994

10308

4.39

277.02

4.1

2.2

12.87

8.46

mm/h

28.22

1839

9480

(3024354) Oxygen [Partial pressure] in Venous blood

399

562

8.13

274.97

3.6

2.2

5.18

4.77

kpa

1.85

373

544

(3028026) IgM [Mass/volume] in Serum or Plasma

412

613

7.73

270.46

1.4

1.9

1.62

1.32

g/l

2.60

383

561

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

219

133

17.80

264.30

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

375

516

8.25

263.34

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

470

833

6.60

261.28

9.5

5.9

1.43

1.31

mmol/l

1.14

457

812

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

497

945

6.20

257.06

2.1

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

625

1463

5.23

256.97

2.1

1.5

—

(3003396) Base excess in Arterial blood by calculation

488

919

6.24

254.84

10.5

7.1

0.86

0.58

mmol/l

0.60

402

724

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

491

931

6.20

254.58

2.1

1.4

—

(3000991) Gas panel - Venous blood

455

810

6.53

251.44

10.7

6.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

578

1307

5.33

246.77

2.1

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

203

125

17.45

243.09

7.1

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

332

435

8.54

242.44

3.8

2.6

23.93

24.36

mmol/l

1.23

311

430

(3027801) Oxygen [Partial pressure] in Arterial blood

474

918

6.03

239.76

10.7

7.1

11.71

14.26

kpa

16.22

453

875

(3031040) Bacteria [#/volume] in Urine by Automated count

1842

9581

3.79

239.70

4.8

2.7

408.90

325.14

e6/l

0.10

101

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

474

919

6.02

239.47

10.7

7.1

5.30

5.06

kpa

5.07

452

874

(3012095) Magnesium [Moles/volume] in Serum or Plasma

654

1681

4.79

238.95

4.1

3.5

0.80

0.83

mmol/l

9.81

606

1602

(3000850) Epithelial cells [#/volume] in Urine

743

2156

4.35

231.50

2.7

1.9

12.55

6.26

e6/l

1.65

672

1883

(3026782) Osmolality of Urine

744

2166

4.34

230.72

3.0

2.0

526.65

569.22

mosm/kgh2o

4.49

648

1814

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

694

1924

4.49

229.51

2.7

2.0

2.02

1.29

e6/l

0.55

353

949

(3020191) Ethanol [Moles/volume] in Serum or Plasma

178

20.17

229.09

1.8

1.2

1.31

1.53

promille

0.57

135

(3021960) Folate [Moles/volume] in Serum or Plasma

705

1984

4.43

228.52

1.6

1.3

18.39

19.64

nmol/l

1.63

639

1757

(3015736) pH of Urine

1327

5771

3.51

225.92

5.6

2.1

5.98

5.95

0.07

815

(3018677) aPTT in Platelet poor plasma by Coagulation assay

573

1392

4.93

223.39

2.4

2.1

30.64

30.11

0.92

560

1357

(3037467) Urinalysis macro (dipstick) panel - Urine

1871

10216

3.59

216.94

4.7

2.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

225

210

11.58

211.21

2.3

1.9

583.22

484.56

ug/l

0.18

213

200

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

667

1915

4.28

208.95

2.8

2.0

3.52

2.50

e6/l

1.12

330

939

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

791

2574

3.91

207.83

2.4

1.9

2.99

2.68

mg/l

2.53

682

2177

(3016502) Oxygen saturation in Arterial blood

414

807

5.86

206.75

11.7

7.6

95.38

96.64

3.41

406

772

(3019309) Folate [Moles/volume] in Red Blood Cells

540

1351

4.73

201.81

1.8

1.5

1112.74

1105.57

nmol/l

0.06

404

990

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

528

1299

4.79

201.46

2.6

1.9

22.64

25.61

3.15

462

1129

(3004789) Transferrin [Mass/volume] in Serum or Plasma

550

1415

4.61

198.22

2.5

1.8

2.44

2.40

g/l

0.53

506

1310

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2302

14830

4.36

196.95

6.8

2.3

69.83

38.91

u/l

28.51

2220

14232

(3019550) Sodium [Moles/volume] in Serum or Plasma

2588

18246

7.94

195.76

24.1

7.3

138.89

139.82

mmol/l

66.86

2540

17570

(3020779) Urea [Moles/volume] in Serum or Plasma

402

802

5.70

195.39

8.6

5.6

8.46

7.74

mmol/l

1.18

387

773

(3023103) Potassium [Moles/volume] in Serum or Plasma

2591

18394

7.90

191.47

24.1

7.3

3.96

3.94

mmol/l

2.91

2540

17636

(3002173) Hemoglobin [Mass/volume] in Arterial blood

397

798

5.64

191.23

11.9

7.7

121.08

123.93

g/l

1.50

390

769

(3015377) Calcium [Moles/volume] in Serum or Plasma

992

3941

3.37

189.16

3.3

4.1

2.35

mmol/l

1.27

867

3606

(3019150) Specific gravity of Urine by Refractometry

800

2801

3.62

186.13

6.9

2.2

1.02

kg/l

0.51

407

(3026008) Bacteria identified in Urine by Culture

801

2861

3.54

179.98

3.4

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

561

1585

4.19

177.48

2.5

1.8

13.56

14.99

umol/l

3.29

525

1492

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

639

2030

3.80

170.70

3.8

2.6

271.81

975.13

ng/l

4.64

414

1381

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2334

15896

4.07

166.99

5.2

3.2

1.78

2.62

mu/l

1.95

2169

14783

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

281

465

6.62

164.86

12.7

8.9

24.35

24.15

mmol/l

0.37

268

451

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2567

18828

6.35

162.97

22.3

6.9

24.18

25.81

mg/l

1.65

2196

13028

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

276

465

6.48

158.97

1.9

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

997

4353

3.02

156.72

3.0

1.9

—

(3042517) Benzodiazepines panel - Urine

162

191.11

156.52

5.7

4.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

172

168

10.85

155.99

5.6

7.6

354.36

409.07

umol/l

3.72

148

146

(3006922) Hepatitis E virus Ab [Presence] in Serum

152

125

12.81

154.26

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1123

5276

2.91

153.73

2.5

1.9

67.97

73.69

nmol/l

8.76

1036

4957

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1981

12539

3.07

153.09

4.1

2.9

14.49

14.42

pmol/l

0.63

1818

11558

(3011397) Hemoglobin [Presence] in Urine by Test strip

739

2790

3.25

148.51

3.2

2.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

144

117

12.93

147.17

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

709

2643

3.27

145.18

2.0

1.5

1.37

1.18

mg/l

0.34

548

1875

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

143

118

12.73

144.74

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

492

1456

3.90

143.99

1.3

1.1

31.76

13.34

iu/ml

4.99

178

450

(3044889) 12 lead EKG panel

1793

10964

2.82

143.93

3.9

2.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

190

236

8.57

143.70

28.4

20.2

1377.23

1393.98

nmol/l

0.09

183

225

(3027945) Reticulocytes/100 erythrocytes in Blood

381

936

4.56

143.32

2.8

2.7

1.91

1.61

3.45

328

839

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

903

3896

2.96

142.89

4.0

2.0

55.54

76.76

ng/l

0.33

554

1803

(3007164) IgA [Mass/volume] in Serum or Plasma

744

2899

3.15

140.86

1.5

1.3

2.59

2.28

g/l

4.19

490

1953

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

564

1881

3.51

137.59

2.9

3.9

2.45

2.43

mmol/l

1.51

478

1667

(3035350) Ketones [Presence] in Urine by Test strip

1315

7002

2.68

137.26

3.7

2.2

0.00

estimate

1.08

293

1176

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

131

103

13.30

136.49

1.8

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2446

18100

4.14

134.07

18.9

6.7

95.09

89.99

ml/min/173m2

22.38

2074

14303

(3009261) Glucose [Presence] in Urine by Test strip

1319

7101

2.65

133.65

3.6

2.2

0.00

estimate

-0.00

281

1139

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

25.98

133.61

1.8

1.4

150.64

141.11

umol/l

0.05

(3021601) Nitrite [Presence] in Urine by Test strip

1311

7046

2.64

133.17

5.1

3.2

0.00

estimate

0.50

286

1159

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

332

774

4.74

132.99

1.4

1.3

172.07

224.39

miu/ml

1.39

104

384

(3004119) Hemoglobin [Mass/volume] in Venous blood

246

450

5.90

129.78

4.0

2.5

130.52

133.51

g/l

0.90

240

441

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

415

1171

4.00

129.21

3.5

5.1

237.13

246.47

u/l

0.47

390

1122

(3002385) Erythrocyte distribution width [Ratio]

2372

17354

3.64

129.10

30.4

9.2

14.38

14.35

0.04

2352

16919

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

277

570

5.29

128.48

1.6

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

779

3296

2.90

125.50

2.9

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1274

6975

2.54

121.44

3.1

2.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

189

286

7.02

120.13

3.3

2.8

5.30

5.01

kpa

3.31

184

271

(3009343) pH of Capillary blood

185

283

6.94

116.36

3.2

2.8

7.40

7.42

1.65

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

181

274

7.00

114.94

3.3

2.8

1.85

1.39

mmol/l

0.70

138

191

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

245

519

5.08

109.54

12.5

8.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

536

1981

3.12

108.51

2.9

2.3

1671.54

720.84

ng/l

1.35

445

1650

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

107

12.61

108.31

1.8

1.3

29.26

8.59

e6/l

1.27

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

107

12.61

108.31

1.8

1.3

34573.77

121.22

e6/l

0.51

(40768797) Stomach Pathology biopsy report

453

1545

3.31

104.72

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

724

3233

2.68

102.49

2.7

2.0

—

(3052851) Hemolysis interference index of Serum or Plasma

183

319

6.07

101.11

2.9

2.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

230

494

4.99

101.03

2.1

2.9

67.58

66.58

g/l

0.87

211

465

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

182

318

6.06

100.31

1.7

1.8

1.44

1.32

g/l

0.69

146

261

(3027974) Hepatitis B virus e Ag [Presence] in Serum

104

135.03

97.72

2.1

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

173

296

6.17

97.38

4.5

2.6

24.96

25.19

mmol/l

0.33

167

286

(3008152) Bicarbonate [Moles/volume] in Arterial blood

211

437

5.15

96.62

10.0

6.5

24.81

24.15

mmol/l

1.27

203

409

(3023511) Choriogonadotropin [Units/volume] in Urine

204

417

5.20

94.81

1.7

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

252

615

4.41

94.43

1.7

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

247

596

4.45

93.91

2.4

2.8

77.48

67.43

e9/l

2.10

161

430

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

107

109

10.17

93.85

13.7

10.7

1282.21

13862.04

u/ml

0.44

(3013945) Hepatitis B virus e Ab [Presence] in Serum

169.26

93.80

2.2

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

20.79

93.55

1.7

1.2

13113.88

57001.82

e6/l

0.65

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2643

22041

5.94

92.64

17.5

5.7

44.47

27.69

u/l

49.52

2612

21311

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

390

1303

3.32

92.64

1.3

1.1

11.71

1.33

u/ml

1.82

109

573

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

766

3667

2.51

92.63

2.8

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1230

7245

2.26

92.09

3.2

2.3

124.31

105.21

ug/l

1.99

1130

6897

(3044290) Cell count panel - Cerebral spinal fluid

11.01

90.97

1.9

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

183

359

5.39

89.01

3.9

2.5

1.44

1.15

mg/l

5.16

178

336

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

184

7.42

88.85

2.1

2.0

743.75

646.67

u/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

152

252

6.33

88.22

4.6

3.8

865.79

336.75

iu/ml

0.46

(3004588) Protein electrophoresis panel - Serum or Plasma

176

337

5.51

87.91

1.9

2.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

154

260

6.21

87.77

2.0

1.4

—

(3019060) Gas panel - Arterial blood

199

432

4.89

86.09

7.2

5.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

755

3712

2.42

85.13

1.7

1.4

1.59

1.34

mmol/l

7.62

683

3276

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

146

243

6.29

84.38

3.2

2.6

2492.80

1728.00

titre

0.33

(3010421) pH of Blood

136

215

6.60

82.65

4.4

2.5

7.40

7.42

2.97

119

198

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

102

9.71

81.60

3.2

2.9

36.69

38.21

0.23

(3024928) Oxygen saturation in Venous blood

128

193

6.91

81.34

2.8

2.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2142

16262

2.43

81.16

5.8

2.4

38.76

35.63

mmol/mol

32.10

1995

15268

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

200

6.77

81.07

1.9

1.6

3.94

3.65

g/l

0.64

119

188

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

200

6.77

81.07

1.9

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

200

6.77

81.07

1.9

1.6

7.38

6.90

g/l

1.76

119

188

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

15.59

80.40

1.5

1.2

—

(40761511) CBC panel - Blood by Automated count

2568

21428

3.94

79.83

20.1

6.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

118

168

7.29

79.02

1.9

1.8

0.68

1.14

g/l

0.42

104

151

(3029937) Albumin [Presence] in Urine by Test strip

688

3362

2.39

77.72

4.0

2.3

0.00

estimate

0.80

272

1102

(3037121) Protein [Mass/volume] in Urine

172

360

5.03

77.59

4.2

0.28

0.21

g/l

0.59

119

207

(3036481) Cortisol [Moles/volume] in Serum or Plasma

287

882

3.52

77.30

2.4

2.5

354.00

393.69

nmol/l

2.63

261

816

(3044941) Cell count panel - Synovial fluid

24.38

77.27

1.4

1.2

—

(1616796) Gas panel - Central venous blood

108

143

7.82

77.06

4.3

2.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

102

127

8.30

76.62

13.4

14.1

0.60

0.64

mmol/l

0.81

116

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

106

139

7.89

76.25

1.4

1.7

0.00

0.01

g/l

0.50

132

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

110

152

7.50

75.62

1.5

1.7

37.71

38.83

g/l

0.68

140

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

111

155

7.42

75.61

1.7

0.00

0.01

g/l

0.50

102

147

(3021788) Differential panel - Synovial fluid

23.93

75.33

1.6

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

193

6.62

75.24

1.7

1.6

12.88

10.30

g/l

3.60

112

180

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2295

18201

2.56

75.03

4.7

2.6

6.11

5.43

mmol/l

52.72

2117

17032

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

207

519

4.23

74.55

4.4

3.0

98.48

76.07

ng/l

2.58

190

474

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

138

247

5.83

73.98

2.6

2.4

—

(3000494) Fungus identified in Specimen by Culture

411

1602

2.84

73.71

1.5

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

664

3265

2.36

73.44

1.3

1.2

1.69

2.43

u/ml

0.64

125

955

(3012501) Base excess in Blood by calculation

119

185

6.68

73.43

4.6

2.5

2.14

2.47

mmol/l

0.65

108

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

101

9.18

73.39

1.2

1.3

440.00

396.36

titre

—

(3026493) Urate [Moles/volume] in Serum or Plasma

625

2994

2.41

73.34

2.7

1.9

343.63

4040.16

umol/l

7.65

550

2799

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

122

197

6.43

72.57

1.3

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

122

197

6.43

72.57

1.3

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

103

139

7.66

72.27

1.4

1.7

0.00

g/l

-0.00

132

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

110

8.62

71.39

2.5

2.6

146.91

154.82

nmol/l

0.23

101

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

194

6.42

71.30

1.9

1.6

2.99

2.84

g/l

0.78

109

182

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

29.87

70.82

1.3

1.4

—

(3020891) Body temperature

136

251

5.65

70.55

8.0

3.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

145

284

5.33

70.49

2.4

1.9

1.59

3.63

ug/l

0.66

131

258

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

133

7.60

68.42

1.2

1.6

—

(3013512) EKG study

599

2896

2.37

68.33

3.9

2.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

15.99

67.58

2.4

2.5

244.79

95.55

ug/min

0.71

(3015235) Bicarbonate [Moles/volume] in Capillary blood

128

7.65

66.73

3.3

2.4

24.71

24.23

mmol/l

0.43

123

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

459

2000

2.55

65.52

1.7

1.4

40476674.63

22945635.72

pmol/l

0.25

378

1752

(3017181) Myelocytes/100 leukocytes in Blood

260

837

3.33

64.76

4.6

4.2

0.59

1.05

2.31

125

283

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

101

8.44

63.47

4.0

3.1

42821.90

41022.77

ug/l

0.29

101

(3029634) Reagin Ab [Titer] in Serum by VDRL

144

307

4.89

63.45

4.2

3.0

15.36

11.00

titre

0.12

(3022313) Gas panel - Capillary blood

108

180

6.20

62.22

3.2

3.0

—

(3023410) Appearance of Cerebral spinal fluid

13.44

61.43

2.3

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

101

160

6.51

61.16

3.2

2.0

16.40

16.82

0.33

(3002179) Metamyelocytes/100 leukocytes in Blood

237

755

3.34

59.93

4.4

4.1

0.56

0.79

0.93

110

244

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

153

360

4.44

59.70

1.2

—

(3021901) Oxygen saturation in Capillary blood

8.66

59.39

2.9

2.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

242

792

3.25

58.54

4.8

4.2

0.03

0.17

1.09

107

241

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

27.04

58.27

4.7

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

10.72

57.79

3.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

113

216

5.41

56.37

1.1

1.67

1.45

g/l

4.67

103

198

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

12.14

55.78

2.5

1.4

—

(3025159) Blasts/100 leukocytes in Blood

232

765

3.22

55.36

4.8

4.2

0.10

1.49

1.35

217

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

167

444

3.94

55.32

2.8

2.1

3.52

3.59

g/l

0.18

162

417

(40768441) Liver Pathology biopsy report

119

7.16

55.16

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

11.16

54.69

1.1

1.2

39.86

30.91

iu/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

141

335

4.38

54.30

1.2

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

115

231

5.15

54.26

2.8

2.5

0.27

u/ml

0.09

122

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

231

774

3.17

53.63

4.5

3.1

1.21

1.23

mmol/l

2.53

207

666

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

+∞

53.29

2.8

0.0

2.44

—

ug/l

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

142

346

4.27

52.92

1.3

1.2

277.78

253.73

u/ml

0.40

108

243

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

197

606

3.42

52.54

1.8

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

201

629

3.37

52.17

2.4

1.8

10.42

13.03

ug/l

0.41

179

565

(3036489) Thrombin time

163

452

3.77

50.82

2.9

1.7

22.62

21.41

1.93

151

400

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

132

314

4.36

50.74

6.6

5.4

2.47

1.84

3.13

124

285

(40761535) Cells panel - Urine sediment

199

633

3.31

50.29

3.6

2.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

101

196

5.31

49.53

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

143

4347

0.29

49.41

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

108

224

4.98

49.10

1.4

1.3

253.57

286.66

ug/g

0.85

140

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

295

1187

2.66

48.85

8.7

3.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

132

325

4.22

48.50

1.2

1.3

125.95

105.17

u/ml

1.46

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

150

406

3.85

48.40

5.0

2.0

184.84

180.63

0.18

143

391

(3034860) Kappa light chains.free [Mass/volume] in Serum

149

5.93

47.61

2.2

3.7

56.16

41.66

mg/l

1.00

120

(3000093) Morphology [Interpretation] in Blood Narrative

8.24

47.47

1.1

—

(40761536) Microorganisms panel - Urine sediment

282

1126

2.68

47.37

4.1

2.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

245

911

2.85

47.18

2.8

2.5

5076.02

7489.05

u/l

0.51

393

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

144

5.98

47.01

2.2

3.8

3.65

1.44

ratio

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

127

311

4.23

46.99

6.8

5.5

0.89

0.93

0.38

119

282

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

149

5.85

46.49

2.2

3.8

43.03

46.32

mg/l

0.08

121

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

191

626

3.20

45.90

3.3

2.2

178.08

144.53

ng/l

0.43

171

551

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

102

215

4.89

45.50

4.2

3.8

53.70

57.04

1.79

102

215

(3023420) DNA double strand Ab [Units/volume] in Serum

9.63

45.13

1.4

1.1

18.00

—

iu/ml

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

186

5.20

45.10

2.4

2.1

129.61

134.19

g/l

0.77

130

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

333

1476

2.43

44.86

2.6

2.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

192

645

3.12

44.24

1.5

1.4

7.80

8.45

u/l

0.33

136

541

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

11.10

44.24

3.1

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

400

1932

2.25

44.15

2.6

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

234

879

2.82

44.15

1.7

381.86

282.60

mu/l

2.83

193

798

(3048929) Epstein Barr virus Ab [Presence] in Serum

193

654

3.10

43.81

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

7.06

42.84

1.6

1.2

49.50

66.20

mmol/l

1.22

(3016018) Differential panel - Cerebral spinal fluid

8.84

42.31

2.3

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

11.45

42.27

1.1

1.0

—

(3017509) Phencyclidine [Presence] in Urine

11.83

41.22

4.6

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

225

4.53

40.30

1.4

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

154

480

3.34

40.12

2.4

1.8

186.31

223.18

pmol/l

3.22

148

464

(3009542) Hematocrit [Volume Fraction] of Blood

2670

24434

4.04

40.06

36.3

10.0

40.39

42.39

4.89

2549

23175

(3017446) Testosterone [Moles/volume] in Serum or Plasma

369

1791

2.22

40.03

2.6

1.9

13.50

14.57

nmol/l

1.51

308

1674

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

161

5.22

39.69

1.4

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

872

5701

1.77

39.53

4.1

2.2

—

(3007461) Platelets [#/volume] in Blood

2671

24486

4.01

39.18

35.8

10.0

239.21

251.35

e9/l

13.79

2628

23667

(3015171) Extractable nuclear Ab [Units/volume] in Serum

102

244

4.30

38.90

1.2

1.1

0.28

0.84

u/ml

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

219

4.46

37.99

1.4

1.5

—

(3035941) MCH [Entitic mass]

2671

24548

3.92

37.72

35.6

9.9

30.26

30.15

2.20

2655

24150

(40760888) Immunoglobulin light chains.free panel - Serum

118

5.88

37.59

2.5

3.7

—

(3024731) MCV [Entitic volume]

2671

24555

3.91

37.56

35.6

10.0

90.49

89.86

10.12

2655

24160

(3026361) Erythrocytes [#/volume] in Blood

2671

24561

3.90

37.42

35.7

10.0

4.53

4.66

e12/l

33.10

2619

23702

(3010813) Leukocytes [#/volume] in Blood

2671

24569

3.89

37.23

35.9

10.0

7.12

6.38

e9/l

41.65

2620

23679

(3000963) Hemoglobin [Mass/volume] in Blood

2671

24578

3.88

37.02

36.0

10.0

135.74

140.12

g/l

38.72

2653

24179

(1761868) Lipid panel - Serum or Plasma

597

9288

0.54

37.00

2.8

2.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

10.97

36.45

1.1

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

178

4.78

36.28

1.4

1.3

—

(4200892) Spirometry reversibility

204

794

2.69

35.82

1.4

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

13.23

35.71

2.9

4.7

—

(3047181) Lactate [Moles/volume] in Blood

105

280

3.86

34.58

7.6

5.8

1.35

1.27

mmol/l

0.26

238

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

113

5.68

33.65

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

255

1141

2.36

33.30

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

225

952

2.48

33.25

3.2

2.1

67.70

76.49

ml/min/173m2

1.72

319

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

8.69

33.16

8.1

10.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

135

3528

0.35

33.02

1.5

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

178

684

2.71

32.01

2.4

2.7

4.52

4.55

pmol/l

0.12

147

609

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

4.81

31.83

1.3

1.6

—

(3011648) Oxygen content in Venous blood

6.43

30.35

1.8

1.9

11.18

11.71

0.29

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

8.92

29.82

1.1

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

8.92

29.82

1.1

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

8.92

29.82

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

8.92

29.82

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

8.92

29.82

1.1

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

8.92

29.82

1.1

1.0

—

(3008295) Osmolality of Serum or Plasma

6.86

28.45

2.1

1.7

285.50

279.53

mosm/kgh2o

0.64

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

191

805

2.47

28.40

2.2

1.6

49.31

39.45

nmol/l

5.02

179

792

(3008898) HLA-B27 [Presence]

101

301

3.44

28.24

1.1

1.0

—

(3051651) Icteric interference index of Serum or Plasma

6.48

28.18

3.3

4.2

—

(3037756) Immunofixation for Serum or Plasma

110

5.27

28.15

1.3

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

11.26

27.57

3.3

1.6

—

(3019225) pH of Specimen

204

900

2.37

27.41

4.0

3.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

179

4.16

26.99

1.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

10.84

26.90

1.4

1.5

12.57

7.95

ug/l

2.37

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

32.20

26.84

1.7

1.2

67.45

49.80

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

161

4.30

26.32

1.4

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

161

4.30

26.32

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

145

4.49

26.20

1.8

1.1

3.21

1.84

iu/l

1.47

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

110

5.08

26.11

1.4

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

110

5.08

26.11

1.4

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

8.04

26.01

1.6

3.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

108

5.08

25.64

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

10.10

25.61

1.1

1.3

146.52

135.07

nmol/l

0.36

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

5.34

25.61

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

4.30

25.15

1.4

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

6.99

25.03

1.1

—

(3019977) pH of Arterial blood

9.76

25.01

3.1

1.5

7.44

7.43

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

39.20

24.88

1.2

1.0

—

mmol/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

311

3.23

24.81

1.6

0.39

0.01

iu/ml

0.91

(3024980) IgG subclass 4 [Mass/volume] in Serum

197

3.83

24.47

1.5

1.7

0.79

0.77

g/l

0.04

155

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

6.29

24.45

1.4

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

202

3.79

24.40

1.6

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

7.37

24.18

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

202

3.74

23.62

9.4

7.1

104.22

104.87

mmol/l

0.39

175

(3039000) Anion gap in Blood

202

3.74

23.62

9.4

7.1

10.76

11.45

mmol/l

0.91

175

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

137

538

2.63

23.58

3.3

4.6

89.45

2206.42

u/ml

1.11

116

473

(3023199) Leukocytes [#/volume] in Pleural fluid

5.12

23.55

1.5

1.4

30633.00

2330.07

e6/l

0.73

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

173

3.94

23.13

1.2

1.1

3.44

5.74

u/ml

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2424

0.35

23.12

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

107

4.84

22.93

3.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

501

3199

1.69

22.89

2.0

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

117

432

2.78

22.71

1.7

2.4

47.27

40.38

u/l

1.62

106

404

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

26.10

22.64

1.8

1.2

26.55

17.73

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

8.19

22.64

1.2

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

8.19

22.64

1.2

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

4.83

22.46

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

160

693

2.39

22.38

2.2

48.58

22.71

au/ml

—

112

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.24

22.21

1.5

30606.89

26609.54

e6/l

0.09

(3012441) Differential panel - Pleural fluid

5.31

22.02

1.5

1.4

—

(3003338) MCHC [Mass/volume]

2207

19645

1.62

21.95

32.2

8.7

333.41

334.46

g/l

5.93

2197

19436

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

162

3.96

21.89

1.1

57.86

34.84

u/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.81

21.05

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

128

4.28

20.92

1.4

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

150

4.00

20.83

2.9

3.4

2.02

1.86

0.06

133

(3040151) Glucose [Moles/volume] in Capillary blood

5.25

20.80

2.5

2.8

7.33

5.80

mmol/l

1.75

(3013139) Helicobacter pylori Ag [Presence] in Stool

185

882

2.18

20.62

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

105

4.63

20.55

1.4

1.2

—

(3045788) Cell count panel - Pleural fluid

5.19

20.52

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2293

20726

1.63

20.04

4.6

3.0

2.67

3.05

mmol/l

73.60

2109

19643

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

112

4.44

19.88

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

19.52

19.49

1.6

1.0

32494.65

150095.38

e6/l

—

(3023419) Bacteria identified in Sputum by Culture

4.84

19.41

1.9

2.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

6.17

19.38

1.2

1.0

335.12

161.23

iu/ml

1.51

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

5.50

19.31

4.0

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

6.58

18.75

2.6

1.6

269.56

1939.87

e6/l

1.24

(3048689) Calprotectin [Mass/mass] in Stool

330

1984

1.75

18.50

2.4

2.9

130.11

135.04

ug/g

0.10

271

1663

(42529406) Shigella sp [Presence] in Stool by Culture

105

410

2.62

18.32

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

104

406

2.62

18.16

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

104

407

2.62

18.07

1.3

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

614

4350

1.53

17.70

3.7

2.0

—

(3033799) Differential panel - Peritoneal fluid

6.81

17.41

2.7

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

17.49

16.91

1.7

—

(3011412) CD3 cells [#/volume] in Blood

4.46

16.83

3.4

2.4

1.47

1.14

e9/l

1.00

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

4.64

16.81

2.3

2.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.48

16.65

2.7

1.6

690.36

8933.41

e6/l

0.78

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

13.46

16.45

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

4.53

16.34

1.3

1.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

14.34

16.30

1.5

2.4

15.34

13.37

umol/l

0.37

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

6.81

16.13

1.1

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

12.84

16.13

1.2

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

5.13

15.99

3.5

1.8

—

(3044007) Cell count panel - Peritoneal fluid

6.39

15.83

3.0

1.7

—

(4146454) Self-monitoring of blood glucose

22.16

15.53

3.1

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

145

3.56

15.43

1.3

1.1

52.95

44.79

u/l

0.10

122

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

190

3.21

15.34

1.3

1.2

3.12

2.10

u/ml

0.58

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

242

1404

1.79

15.25

3.2

5.3

9.57

59.01

ug/l

1.14

210

1109

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

171

3.32

15.18

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

11.84

15.04

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

4.32

15.00

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

4.42

14.26

1.3

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

179

3.17

14.12

1.4

1.3

4.29

5.36

u/ml

0.24

(3027456) Digoxin [Moles/volume] in Serum or Plasma

4.96

14.04

2.8

2.4

1.03

0.91

nmol/l

0.37

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.81

14.01

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

12.73

13.88

1.6

1.1

100.33

85.16

1.00

(3000034) Microalbumin [Mass/volume] in Urine

5.57

13.83

3.5

2.0

99.63

27.53

mg/l

0.74

(3024932) HLA-DR beta [Type]

6.51

13.64

1.0

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

184

3.09

13.50

1.2

1.4

—

(3024471) HLA-A [Type]

6.09

13.39

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

21.24

13.32

1.3

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

4.87

13.31

1.7

2.3

1.69

1.09

g/24h

—

(40768446) Kidney Pathology biopsy report

10.50

13.22

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

112

524

2.19

13.14

1.2

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

4.42

13.08

1.2

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

4.42

13.08

1.2

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

4.42

13.08

1.2

1.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

260

2.70

13.00

1.4

1.3

16.34

28.17

u/l

2.15

220

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

313

2.54

12.96

1.6

2.3

13.40

10.04

mg/l

2.10

299

(21494890) Protein electrophoresis panel - 24 hour Urine

5.24

12.95

1.3

2.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

591

4390

1.44

12.94

1.6

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

302

2.56

12.88

1.1

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1878

16809

1.37

12.67

3.6

3.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

189

1077

1.81

12.64

1.3

24.41

27.07

iu/l

0.50

138

906

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

318

2.49

12.55

1.7

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

152

3.20

12.33

1.5

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

14.38

12.26

2.9

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

14.38

12.26

2.8

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

26.80

12.04

2.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2224

20539

1.43

11.97

4.2

2.9

4.44

4.94

mmol/l

95.09

2052

19593

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

223

2.73

11.64

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

100

3.63

11.33

2.9

3.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

118

599

2.01

11.22

1.7

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

136

3.20

11.10

2.3

2.4

—

(3011985) Renin [Units/volume] in Plasma

131

3.24

11.09

1.4

1.7

101.85

65.17

mu/l

0.32

117

(3000012) Reticulocyte production index

108

3.46

10.84

2.4

—

(3029075) Extractable nuclear Ab panel - Serum

8.86

10.75

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

153

862

1.82

10.65

1.4

1.2

—

(3042631) Mycobacterium sp identified in Specimen

111

3.36

10.40

2.5

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

209

2.66

10.26

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

160

926

1.77

10.19

3.0

2.4

5.39

4.15

e9/l

0.44

123

808

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

199

3114

0.61

10.13

1.4

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.29

10.11

4.7

1.8

—

(3016228) CD19 cells/100 cells in Blood

5.29

10.11

4.8

1.8

8.35

9.55

0.27

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2201

20453

1.38

10.05

4.2

2.8

1.32

1.47

mmol/l

53.12

2029

19471

(3005322) IgE [Units/volume] in Serum or Plasma

160

930

1.76

10.04

1.2

168.56

339.59

u/ml

1.91

146

863

(3044242) Glucose [Moles/volume] in Arterial blood

8.46

10.03

2.4

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

129

3.13

10.03

2.0

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

3.46

10.01

1.4

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

167

2.85

9.96

4.1

2.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.16

9.89

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

26.10

9.81

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

26.10

9.81

1.2

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

26.10

9.81

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

20.09

9.79

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

735

5893

1.34

9.74

1.6

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

137

3.02

9.69

1.9

1.2

—

(3000492) Spirometry study

292

1999

1.52

9.50

1.5

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

166

993

1.71

9.43

1.4

—

(3042733) HLA Ab [Presence] in Serum

8.05

9.33

2.1

3.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

208

2.58

9.31

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

13.70

9.17

1.1

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.04

9.01

1.7

1.2

106.48

26.85

g/l

0.39

(3001019) Free T4 and TSH panel - Serum or Plasma

1516

0.49

9.01

1.7

1.5

—

(4034850) Laboratory test

430

2.06

8.96

13.5

5.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

3.85

8.95

2.3

2.6

830.25

535.33

e6/l

0.75

(3000330) Specific gravity of Urine by Test strip

499

1.98

8.95

3.9

2.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

18.65

8.93

1.1

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

237

2.43

8.89

1.2

1.3

—

(4035726) Immunohistochemistry procedure

211

1367

1.59

8.78

1.5

1.4

—

(40768443) Skin Pathology biopsy report

106

568

1.90

8.68

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

3.48

8.64

2.0

1.5

25.08

30.91

mg/l

0.24

(40768804) Tissue Pathology biopsy report

843

6995

1.30

8.51

2.0

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

4.31

8.40

1.6

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

220

1456

1.56

8.36

3.8

2.8

30.77

31.64

0.60

161

1021

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

122

2.98

8.35

1.3

1.4

299.60

352.25

pmol/l

0.50

114

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

+∞

8.33

1.1

0.0

—

mmol/l

—

(3013762) Body weight Measured

8.54

8.29

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

101

543

1.89

8.21

2.3

2.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

4.37

8.14

6.9

1.7

163.15

142.12

0.62

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

254

2.31

8.09

2.7

2.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2105

19620

1.31

8.03

3.8

2.7

1.39

1.22

mmol/l

13.34

1930

18625

(3049717) Cytology report of Urine Cyto stain

320

2.15

7.99

2.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.14

7.99

1.0

1.1

—

(3022145) Colonoscopy Study observation

248

1703

1.50

7.95

1.3

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

324

2.13

7.75

2.3

2.4

13.11

6.98

umol/l

0.55

237

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.66

7.73

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

455

1.94

7.70

1.6

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.34

7.68

1.3

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

7.43

7.66

1.4

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

3.60

7.57

2.4

2.7

0.16

0.21

e9/l

0.85

(3039443) Prostate specific Ag panel - Serum or Plasma

620

0.29

7.42

1.4

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

10.88

7.29

2.6

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.49

7.17

2.1

2.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.27

7.10

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

218

2.32

7.09

1.3

1.2

—

(3022621) pH of Urine by Test strip

129

782

1.68

7.04

2.5

2.0

—

(3005570) Glucose [Moles/volume] in Urine

3.16

6.98

1.7

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.46

6.90

1.4

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

5.46

6.90

3.4

1.5

25.32

31.50

umol/l

1.34

(3013247) Albumin in CSF/Albumin in Serum or Plasma

13.80

6.88

1.1

1.0

4.41

4.42

mg/g

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.27

6.83

3.1

2.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

8.27

6.82

1.0

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

8.27

6.82

1.1

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.10

6.76

4.9

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

433

1.90

6.76

1.8

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.65

6.75

2.8

3.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

105

2.88

6.63

1.5

1.2

—

nmol/l

—

(3024263) Appearance of Synovial fluid

7.81

6.61

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

111

2.81

6.58

1.4

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

102

2.86

6.36

1.0

1.2

0.49

0.43

g/l

0.37

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.46

6.28

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

103

2.83

6.26

1.0

1.2

3.30

3.47

g/l

0.14

(3027135) IgG subclass 1 [Mass/volume] in Serum

103

2.83

6.26

1.0

1.2

6.73

6.61

g/l

0.06

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

+∞

6.25

1.2

0.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

+∞

6.25

1.2

0.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

126

2.64

6.22

2.6

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.74

6.14

1.6

1.1

7.72

14.45

g/l

1.25

(3004616) Nuclear Ab [Presence] in Serum

3.30

6.13

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.12

6.08

1.5

1.2

100.09

95.29

0.23

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

112

1777

0.61

6.01

1.4

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

3.88

5.98

1.0

1.2

—

85.00

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

159

2.41

5.95

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

7.25

5.92

1.1

—

(4062490) Immunoglobulin typing, IgG

101

2.79

5.89

1.0

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

3.79

5.81

1.0

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

11.15

5.79

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.92

5.71

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.92

5.71

1.5

1.2

96.82

95.56

0.06

(3035320) C reactive protein [Mass/volume] in Body fluid

3.04

5.64

1.9

2.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

12.89

5.58

1.6

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

406

1.82

5.45

1.8

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.24

5.44

1.2

1.1

1518.95

1545.40

miu/ml

0.03

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

112

2.61

5.38

1.1

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

2.58

5.29

1.1

1.6

—

(3014271) Vancomycin [Susceptibility]

11.28

5.29

3.1

2.4

—

(3002256) Pathology report gross observation

281

2127

1.36

5.27

1.3

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

+∞

5.21

3.2

0.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

+∞

5.21

3.2

0.0

—

(3025130) Human papilloma virus identified in Specimen

326

1.89

5.18

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

204

2.13

5.08

1.7

2.0

6.24

5.99

mmol/24h

0.11

187

(3004451) EKG impression Narrative

5.21

5.07

1.5

1.2

—

(3017569) Oxygen content in Arterial blood

5.67

5.06

3.1

2.3

—

(3034426) Prothrombin time (PT)

3.57

5.04

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

3.13

4.91

1.6

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

112

2.52

4.87

1.1

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

7.72

4.84

1.8

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

236

2.01

4.80

5.5

2.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

11.46

4.78

1.0

1.9

—

(3022689) Creatine [Moles/volume] in Urine

9.02

4.78

1.7

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

526

1.66

4.65

1.9

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

267

1.93

4.64

1.7

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.02

4.62

1.0

1.2

—

(3017704) Immunofixation for Urine

5.02

4.62

1.4

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.30

4.62

1.2

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

10.02

4.52

1.1

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.83

4.49

1.4

1.3

82.54

124.23

nmol/24h

0.67

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

142

2.27

4.47

1.1

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

399

0.32

4.45

9.8

1.7

13.48

12.97

0.81

394

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.81

4.44

1.7

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.07

4.40

1.2

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.26

4.31

1.5

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

4.26

4.31

4.2

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

113

2.40

4.31

1.1

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

120

2.35

4.25

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

156

1111

1.43

4.24

1.2

1.1

142.49

151.09

iu/ml

0.08

428

(3005988) Vibrio sp identified in Specimen by Organism specific culture

114

2.38

4.23

1.1

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

114

2.38

4.23

1.1

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

133

2.27

4.22

1.8

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.86

4.19

1.3

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

3.43

4.18

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

383

1.71

4.08

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

104

2.42

4.05

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.63

4.05

1.9

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

626

5394

1.21

4.05

3.3

3.5

1.96

2.36

ug/l

0.29

536

5010

(3044927) Protein electrophoresis panel - Urine

4.46

3.93

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1064

0.61

3.88

1.5

—

(3045424) Erythrocytes [Presence] in Urine

172

2.05

3.85

1.5

1.3

—

(3045142) Bone marrow Pathology biopsy report

120

2.26

3.80

1.3

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

8.77

3.77

1.3

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

134

2.18

3.73

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.68

3.67

7.4

3.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.51

3.60

1.1

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.51

3.60

1.1

2.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

859

0.59

3.59

1.6

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

232

0.30

3.59

2.7

3.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

232

0.30

3.59

5.4

6.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

845

0.58

3.57

1.6

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.95

3.57

1.1

2.2

—

(4281824) Cell count and differential, peritoneal fluid

178

1.98

3.53

1.4

1.1

—

(3035880) pH of Pleural fluid

3.05

3.52

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

2.30

3.52

1.1

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

6.17

3.50

1.3

1.2

16.02

34.14

nmol/l

—

(3013637) Mi-2 Ab [Presence] in Serum

10.02

3.49

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

10.02

3.49

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

10.02

3.49

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

10.02

3.49

1.0

—

(3005033) Fetal Nuchal fold Thickness US

836

0.59

3.44

1.6

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.56

3.42

1.4

1.0

—

(40757373) Influenza virus identified in Isolate

5.01

3.37

1.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.94

3.28

1.1

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

8.59

3.26

1.5

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

131

953

1.39

3.23

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.35

3.19

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.26

3.13

1.1

2.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.51

3.11

1.0

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

5.01

3.05

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

244

1961

1.27

3.03

1.8

1.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.75

2.98

1.1

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.75

2.98

1.1

2.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

2.09

2.98

1.4

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

996

0.65

2.96

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

994

0.66

2.94

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.72

2.92

1.1

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

738

0.60

2.92

1.8

—

(1002224) Polysomnography panel

700

1.43

2.90

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.10

2.88

2.1

3.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.44

2.87

6.9

4.6

27.34

36.25

mu/l

0.30

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

988

0.66

2.86

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

986

0.66

2.83

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.34

2.81

1.5

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.58

2.78

3.4

3.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

2.75

0.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.34

2.75

1.0

—

(4212803) Bone marrow aspirate examination

8.34

2.75

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

8.34

2.75

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

6.01

2.70

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.01

2.70

1.3

1.1

—

(44813793) Dust mix specific IgE antibody measurement

2.13

2.64

1.2

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1064

0.69

2.63

1.7

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

490

1.48

2.60

1.1

1.62

7.09

u/ml

—

122

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.01

2.56

1.1

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

181

0.33

2.52

1.0

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.23

2.51

2.6

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

380

1.54

2.51

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.38

2.47

1.4

3.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.82

2.46

1.1

1.0

—

(3014891) Appearance of Pleural fluid

6.26

2.37

1.6

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.62

2.35

1.1

1.2

143.92

181.60

mmol/24h

1.06

(40768800) Prostate Pathology biopsy report

372

0.51

2.35

1.2

—

(3002619) Bacteria identified in Specimen by Culture

3.22

2.30

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

2.12

2.28

1.5

2.42

1.05

u/field

0.51

(3005011) Chlamydia sp Ab [Titer] in Serum

4.62

2.27

1.3

1.8

—

(21494434) Karyotype in Bone marrow

2.10

2.22

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

451

1.45

2.18

1.5

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

220

1.64

2.12

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

396

1.47

2.12

1.4

1.5

0.24

0.49

nmol/l

2.96

323

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.99

2.05

1.2

1.1

0.70

1.80

u/ml

—

(3051593) INR in Capillary blood by Coagulation assay

4.01

2.04

5.7

22.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.55

1.94

1.2

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

628

0.66

1.91

1.3

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

117

1.80

1.74

1.7

1.3

75.90

81.82

umol/l

0.56

117

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

449

1.39

1.71

2.1

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.58

1.61

1.4

1.3

389.40

385.43

umol/24h

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.70

1.58

1.0

1.1

0.25

0.38

nmol/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

219

0.50

1.52

1.1

1.3

1.47

1.52

g/l

0.30

219

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.60

1.51

1.6

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

452

0.66

1.48

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

2.44

1.48

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.13

1.44

1.0

1.2

1.09

155.72

mg/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

238

1.48

1.39

1.3

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.90

1.39

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.90

1.39

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

732

0.75

1.36

1.5

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.94

1.36

1.2

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1166

0.80

1.35

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

2.78

1.28

7.2

5.6

0.16

0.28

umol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

360

3250

1.12

1.27

1.6

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

377

0.66

1.27

1.2

1.0

9.02

3.66

u/ml

0.49

160

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

1.79

1.27

3.3

4.3

61.40

130.80

nmol/l

1.87

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

433

0.69

1.23

1.3

2.86

3.98

ug/l

0.77

400

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

127

0.47

1.16

2.3

3.9

22.40

32.42

u/ml

—

127

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.50

1.15

2.0

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.50

1.15

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

1.90

1.12

8.5

1.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.26

1.10

1.7

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

122

1.56

1.02

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

404

0.71

1.01

1.1

1.0

3.75

3.01

u/ml

0.13

202

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

829

0.80

1.00

1.4

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.18

0.98

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

469

0.74

0.97

1.1

0.50

2.18

u/ml

2.81

232

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1027

0.83

0.93

1.5

4.40

2.74

mg/l

1.40

619

(3003888) Timothy IgE Ab [Units/volume] in Serum

475

0.75

0.91

1.2

1.1

3.57

7.68

u/ml

1.33

262

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.15

0.91

1.3

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.07

0.89

1.2

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.07

0.89

1.2

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.00

0.87

1.3

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.63

0.84

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

318

0.72

0.81

1.2

1.3

182.83

209.98

pmol/l

0.39

318

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.82

0.79

1.3

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.79

0.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

106

1.51

0.78

1.8

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

316

0.73

0.78

1.2

1.0

0.09

0.87

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

151

0.59

0.78

1.0

—

(40768795) Lymph node Pathology biopsy report

157

1.40

0.76

1.9

1.2

—

(3001556) Androgen free Index in Serum or Plasma

2.09

0.74

1.6

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.51

0.69

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

258

0.73

0.63

1.6

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

453

0.81

0.58

1.2

1.1

0.35

1.62

u/ml

2.62

205

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.51

0.56

1.0

1.1

1.21

1.05

ratio

—

(3002523) Influenza virus A Ag [Presence] in Specimen

503

0.83

0.54

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

503

0.83

0.54

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

414

0.82

0.52

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

288

1.22

0.50

2.6

3.5

20.97

27.30

u/ml

0.53

282

(3014599) Egg white IgE Ab [Units/volume] in Serum

179

0.72

0.50

1.1

1.0

0.39

1.83

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

144

0.69

0.49

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

187

0.75

0.45

2.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

523

0.86

0.44

1.2

1.1

1.51

2.48

u/ml

0.55

262

(3038177) Helicobacter pylori Ab [Presence] in Serum

368

1.17

0.43

1.5

1.1

—

(3018133) Calcium [Moles/volume] in Urine

0.00

0.41

0.0

1.5

—

2.84

—

(3020874) Milk IgE Ab [Units/volume] in Serum

179

0.78

0.35

1.1

0.14

4.05

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

322

1.15

0.32

4.2

2.2

15.45

28.81

mg/l

1.47

197

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

102

1.28

0.30

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

1.22

0.25

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.18

0.24

4.2

3.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

331

3417

0.96

0.24

2.3

0.53

0.81

ug/l

7.71

221

1727

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

602

1.08

0.22

1.6

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.7

—

1.42

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

156

0.83

0.21

1.5

2.0

19.88

26.77

ug/l

0.54

151

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

78.75

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.6

—

(40758292) HTLV I+II Ab panel - Serum

1.16

0.21

1.6

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

268

1.12

0.20

1.2

1.1

—

8.70

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.20

0.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.20

0.0

1.1

—

(3015183) Erythrocyte sedimentation rate

113

0.80

0.20

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.71

0.16

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.16

0.16

1.6

2.6

20.25

873.74

ug/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

130

0.85

0.16

1.0

1.1

—

(40768793) Breast Pathology biopsy report

369

0.92

0.15

1.4

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

436

4427

0.98

0.12

3.2

3.0

23.99

20.68

2.04

137

1695

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

333

1.05

0.07

1.1

5.00

3.63

u/ml

—

215

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.04

0.07

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

105

0.86

0.06

3.7

9.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

141

0.92

0.05

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

179

0.95

0.03

1.1

1.3

24.76

36.16

nmol/l

0.98

161

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

0.86

0.00

1.8

2.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.95

-0.00

3.5

2.0

183.63

195.99

u/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.93

-0.00

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

5.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.5

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: IBD_VIRAL_HEPATITIS – Viral hepatitis, IBD co-morbidity

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Viral hepatitis, IBD co-morbidity

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Viral hepatitis, IBD co-morbidity (IBD_VIRAL_HEPATITIS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints